While research is still in its early stages, CBD may offer potential benefits for digestive disorders like irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Further studies are needed to confirm these findings.

Cannabidiol (CBD) interacts with the endocannabinoid system (ECS), a complex network of receptors and neurotransmitters that plays a crucial role in regulating inflammation.